GSR II Meteora (NASDAQ:GSRM) announced in an 8-K this morning that it secured shareholder approval for its combination with Bitcoin Depot at a special meeting June 28.
A further 3,686,863 shares were redeemed in connection with the vote, bringing GSR II’s final redemption rate to about 89% and leaving it with about $35 million in trust at close.
Although this may have been considered high in other SPAC cycles, it ranks as the 10th lowest redemption rate among the 37 SPACs that have gotten through completion votes so far in 2023.
This trust capital would have been more than enough on its own to satisfy the combination’s minimum cash condition, which was dropped to $8 million in an amendment earlier this month. But, the SPAC also added $50 million in new funding to the deal last week through a mix of PIPE and non-redemption agreements.
PIPE investors agreed to purchase 4,300,000 Series A Preferred shares, which will rank senior to common stock with regards to dividends and distributions but will not hold voting rights. Investors also agreed not to redeem 700,000 shares at the vote.
GSR II initially announced its $755 million combination with Bitcoin Depot in August 2022. Atlanta-based Bitcoin Depot manages a network of ATMs and retail payment points allowing consumers to make cash deposits and withdrawals from bitcoin wallets with about 6,440 locations.
In April, it picked up a contract for 80 more kiosks at Jacksons Food Stores a month after agreeing to deploy 125 in GetGo Café locations in the Midwest and Mid-Atlantic regions.
ADVISORS
- Oppenheimer & Co. Inc. is serving as financial advisor to GSRM.
- Latham & Watkins LLP is serving as legal advisor to GSRM.
- Kirkland & Ellis LLP is serving as legal advisor to Bitcoin Depot.
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...